1. Symjepi, an epinephrine injector manufactured by Sandoz, was approved for the treatment of severe allergic reactions in children.
2. Eli Lilly & Co. received approval for its preventive migraine treatment Emgality. It is a monthly, self-administered injection.
3. Eluvia drug-eluting vascular stent, manufactured by Boston Scientific, slowly releases the drug paclitaxel to prevent tissue regrowth for the treatment of peripheral artery disease.
4. Leica Microsystem’s Augmented Reality Glow800 surgical florescence was approved for vascular neurosurgery. The florescence allows surgeons to observe cerebral anatomy in natural color.
More articles on supply chain:
Apple Watch: FDA-cleared for electrocardiogram screening
FDA scolds pharmaceutical lab for operating microbrewery in drug testing space
Amazon, Merck, Accenture to launch data-driven drug development platform
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
